Industry News

Industry News

New radiation therapy technology takes weeks off of lung cancer treatments - Elekta's Versa HD™

Sep 23, 2013

On September 4, Kettering Medical Center (Kettering, Ohio) became the first clinic in North America to use Elekta's Versa HD™ system to treat a patient, a 71-year-old woman with medically inoperable lung cancer. The rapid speed of radiosurgery with Versa HD enabled Kettering physicians to reduce the number of treatment sessions for this patient from seven weeks to three days... Read More

Discovery of Protein 'motif' crucial to telomerase activity offers insight in the hunt for drugs to block enzyme highly active in most cancers

Sep 23, 2013

It is difficult to underestimate the importance of telomerase, an enzyme that is the hallmark of both aging and the uncontrolled cell division associated with cancer. In an effort to understand and control telomerase activity, researchers at The Wistar Institute have discovered a protein "motif," named TFLY, which is crucial to the function of telomerase... Read More

Mass-spectrometry-based method adapted to profile ribsomes and associated factors

Sep 23, 2013

In molecular biology, the ribosome represents the machinery necessary to assemble proteins, the building blocks of life. In this process, information encoded in the genome's DNA is first transcribed to messenger RNA in the nucleus, then transported to the ribosome where protein-assembly instructions are put in motion to translate the code into actual proteins... Read More

A promising way to boost the body's immune surveillance via p53, "the genome guardian" in the fight against cancer

Sep 23, 2013

Researchers at A*STAR's Singapore Immunology Network (SIgN) have discovered a new mechanism involving p53, the famous tumour suppressor, to fight against aggressive cancers. This strategy works by sabotaging the ability of the cancer cells to hide from the immune system... Read More

Hormone fluctuations, immune cells and breast cancer risk

Sep 23, 2013

University of Adelaide researchers have made a major discovery that highlights the important role played by immune cells in the risk of developing breast cancer. Researchers have focused their efforts on immune cells known as macrophages in the breast, and how the role of these cells changes because of fluctuations in hormones during different times of the month... Read More

Tackling drug-resistant cancers using a genome-forward approach

Sep 23, 2013

If you really want to understand why a particular human cancer resists treatment, you have to be able to study that tumor - really study it - in a way that just isn't possible in humans. Cancer biologists have been developing a new approach to this challenge, by transplanting human cancers directly from patients to mice whose crippled immune systems will allow those human tissues to grow... Read More

Researchers reveal that proteins delivering leucine to prostate cancer cells may offer therapeutic targets

Sep 22, 2013

Like normal cells, cancer cells require amino acids for growth, maintenance, and cell signaling, and L-type amino acid transporters (LATs) are the delivery vehicles that supply them... Read More

New technique helps bring genome's 'dark matter' into the light

Sep 22, 2013

Using technology he helped develop, Vanderbilt University scientist Bryan Venters, Ph.D., has shed new light on the "dark matter" of the genome and has begun to explore a possible new approach to treating cancer... Read More

Researchers reveal that proteins delivering leucine to prostate cancer cells may offer therapeutic targets

Sep 22, 2013

Like normal cells, cancer cells require amino acids for growth, maintenance, and cell signaling, and L-type amino acid transporters (LATs) are the delivery vehicles that supply them... Read More

New technique helps bring genome's 'dark matter' into the light

Sep 22, 2013

Using technology he helped develop, Vanderbilt University scientist Bryan Venters, Ph.D., has shed new light on the "dark matter" of the genome and has begun to explore a possible new approach to treating cancer... Read More

Previous Page   Next Page